Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.018 | 0.8 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.8 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |